Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
Losordo
Douglas W
DW
St Elizabeth's Medical Center, 736 Cambridge St, Boston, Mass 02135, USA. douglas.losordo@tufts.edu
Dimmeler
Stefanie
S
D043925:Angiogenesis Inducing Agents / Q000494:pharmacology / Q000627:therapeutic use*; D042501:Angiogenic Proteins / Q000235:genetics / Q000502:physiology / Q000627:therapeutic use*; D000818:Animals; D002986:Clinical Trials as Topic; D005121:Extremities / Q000098:blood supply; D015316:Genetic Therapy; D006801:Humans; D007511:Ischemia / Q000188:drug therapy; D023421:Models, Animal; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D018919:Neovascularization, Physiologic / Q000187:drug effects; D011993:Recombinant Fusion Proteins / Q000502:physiology; D013552:Swine; D016896:Treatment Outcome
D043925:Angiogenesis Inducing Agents; D042501:Angiogenic Proteins; D011993:Recombinant Fusion Proteins